Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Lipshutz, Christian Cabou, Stephen Worland

Premium

The Institute for Systems Biology has appointed Robert Lipshutz to be chief business officer and senior vice president for strategic partnerships.

Lipshutz spent nearly two decades at Affymetrix in various roles, focusing on business development, licensing, diagnostics, and emerging markets, and most recently was Affy's senior vice president for corporate development.


Illumina said last this week that Christian Cabou, who is senior vice president, general counsel and secretary, has notified the company that he plans to retire sometime early next year.

Cabou has worldwide responsibility for all of the company's legal and intellectual property matters and is also Illumina's code of ethics compliance officer. Prior to joining Illumina in 2006, Cabou was general counsel for GE Global Research.


GenMark Diagnostics said last week that Stephen Worland has been appointed to its board of directors.

Worland is currently president and CEO of Effector Therapeutics. He was president and CEO and a director of Anadys Pharmaceuticals from 2007 until the company was acquired by Roche in 2011.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.